Carbon Dots @ Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy

Fengshou Wu*, Liangliang Yue, Huifang Su, Kai Wang, Lixia Yang, Xunjin ZHU

*Corresponding author for this work

Research output: Contribution to journalJournal articlepeer-review

70 Citations (Scopus)

Abstract

Photosensitizers are light-sensitive molecules that are highly hydrophobic, which poses a challenge to their use for photodynamic therapy. Hence, considerable efforts have been made to develop carriers for the delivery of PSs. Herein, we synthesized a new theranostic nanoagent (CQDs@PtPor) through the electrostatic interaction between the tetraplatinated porphyrin complex (PtPor) and the negatively charged CQDs. The size and morphology of as-prepared CQDs and CQDs@PtPor were characterized by a series of methods, such as XRD, TEM, XPS, and FTIR spectroscopy. The CQDs@PtPor composite integrates the optical properties of CQDs and the anticancer function of porphyrin into a single unit. The spectral results suggested the effective resonance energy transfer from CQDs to PtPor in the CQDs@PtPor composite. Impressively, the CQDs@PtPor composite showed the stronger PDT effect than that of organic molecular PtPor, suggesting that CQDs@PtPor is advantageous over the conventional formulation, attributable to the enhanced efficiency of 1O2 production of PtPor by CQDs. Thus, this CQDs-based drug nanocarrier exhibited enhanced tumor-inhibition efficacy as well as low side effects in vitro, showing significant application potential in the cancer therapy.

Original languageEnglish
Article number357
JournalNanoscale Research Letters
Volume13
DOIs
Publication statusPublished - 2018

Scopus Subject Areas

  • Materials Science(all)
  • Condensed Matter Physics

User-Defined Keywords

  • Carbon dots
  • Energy transfer
  • Photodynamic therapy
  • Photoluminescence
  • Porphyrin

Fingerprint

Dive into the research topics of 'Carbon Dots @ Platinum Porphyrin Composite as Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy'. Together they form a unique fingerprint.

Cite this